China Gives Nod to Bio-Thera Solutions' Clinical Trials for Anti-Tumor Drug Combo
China Gives Nod to Bio-Thera Solutions' Clinical Trials for Anti-Tumor Drug Combo
中國對Bio-Thera Solutions的抗腫瘤藥物組合臨床試驗表示贊同
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊